Browsing by Author Svetlana Ignjatović

Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
1-Jul-2012Adiponectin, non-esterified fatty acids and antiphospholipid antibodies in type II diabetes mellitusMirjana Bećarević ; Jelena Seferović; Svetlana Ignjatović; Sandra Singh; Nada Majkić-Singh
1-Sep-2019Adiponectin: a therapeutic target in the antiphospholipid syndrome?Mirjana Bećarević ; Božana Nikolić ; Svetlana Ignjatović
1-Dec-2018Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndromeMirjana Bećarević ; Marija Sarić; Ljudmila Stojanović; Duško Mirković; Violeta Dopsaj; Svetlana Ignjatović
1-May-2017Antiphospholipid Antibodies and Renal Impairment Parameters in Diabetic Nephropathy: Preliminary DataMirjana Bećarević ; Velibor Čabarkapa ; Mirjana Đerić ; Svetlana Ignjatović
1-Apr-2013Apoptosis, annexin a5 and anti-Annexin a5 antibodies in the antiphospholipid syndromeMirjana Bećarević ; Svetlana Ignjatović; Nada Majkić-Singh
12-Nov-2012Deterioration of thromboses in primary antiphospholipid syndrome: TNF-alpha and anti-annexin A5 antibodiesMirjana Bećarević ; Svetlana Ignjatović; Nada Majkić-Singh
1-Dec-2016Double positivity of the IgG isotype of both anticardiolipin and anti-β2gpI antibodies is associated with the highest number of vascular impairment parameters in patients with primary antiphospholipid syndrome: preliminary dataMirjana Bećarević ; Duško Mirković; Svetlana Ignjatović
1-May-2016The IgM isotype of anti-annexin A5 antibodies and multiple positivity of conventional antiphospholipid antibodies: increasing the number of clinical manifestations of primary antiphospholipid syndromeMirjana Bećarević ; Ljudmila Stojanović; Svetlana Ignjatović; Violeta Dopsaj
1-Oct-2016Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary dataMirjana Bećarević ; Svetlana Ignjatović
1-Aug-2011Significant association of antiphospholipid antibodies and TNF-alpha: Marker of severe atherogenic profile of patients with type II diabetes mellitus without micro and/or macrovascular complicationsMirjana Bećarević ; Jelena Seferović; Svetlana Ignjatović; Sandra Singh; Nada Majkić-Singh
Showing results 1 to 10 of 10